|
Role of metastases-directed therapy (MDT) in the management of solitary metastatic prostate cancer. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Endocyte (Inst) |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Novocure |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |